The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
As of January 2021 Amgen has a market cap of $146.15 B. This makes Amgen the world's 80th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2021 | $138.84 B | 3.73% |
2020 | $133.85 B | -6.11% |
2019 | $142.56 B | 16.32% |
2018 | $122.56 B | -2.91% |
2017 | $126.23 B | 16.06% |
2016 | $108.76 B | -11.13% |
2015 | $122.39 B | 1.05% |
2014 | $121.12 B | 40.7% |
2013 | $86.08 B | 32.05% |
2012 | $65.19 B | 15.83% |
2011 | $56.28 B | 10% |
2010 | $51.16 B | -9.1% |
2009 | $56.28 B | -6.91% |
2008 | $60.46 B | 19.78% |
2007 | $50.48 B | -36.62% |
2006 | $79.64 B | -17.48% |
2005 | $96.52 B | 19.42% |
2004 | $80.82 B | 1.9% |
2003 | $79.31 B | 27.29% |
2002 | $62.31 B | 5.57% |
2001 | $59.02 B |